Biogen’s mixed Alzheimer’s data; Two new startups launch; and morenews2026-07-18T10:00:14+00:00July 18th, 2026|Endpoints News|
Midsize biotechs press White House to drop CMS pricing rulesnews2026-07-17T18:42:39+00:00July 17th, 2026|Endpoints News|
Midsize biotechs press White House to drop CMS pricing rulesnews2026-07-17T18:42:39+00:00July 17th, 2026|Endpoints News|
Celcuity got its cancer drug approved. Then its stock dippednews2026-07-17T18:03:35+00:00July 17th, 2026|Endpoints News|
Celcuity got its cancer drug approved. Then its stock dippednews2026-07-17T18:03:35+00:00July 17th, 2026|Endpoints News|
GSK plans large study to see if shingles vaccine can prevent dementianews2026-07-17T14:52:02+00:00July 17th, 2026|Endpoints News|
GSK plans large study to see if shingles vaccine can prevent dementianews2026-07-17T14:52:02+00:00July 17th, 2026|Endpoints News|
Dimerix buys a kidney injury drug; Arpeggio appears to be winding downnews2026-07-17T14:41:37+00:00July 17th, 2026|Endpoints News|
Dimerix buys a kidney injury drug; Arpeggio appears to be winding downnews2026-07-17T14:41:37+00:00July 17th, 2026|Endpoints News|
Updated: BlossomHill and Latigo join flourishing IPO queue with cancer, pain drugsnews2026-07-17T13:54:42+00:00July 17th, 2026|Endpoints News|